Menu Back toSession-8-Final-Panel-Discussion-and-Key-Takeaways-Where-are-we-Heading-in-Terms-of-Transparency
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Global Clinical Trials Transparency Conference
Session 8: Where are we Heading? The US and EU Industry associations’ perspective
Merete Joergensen, MBA, MSc
- Senior Trial Disclosure Director, Clinical Reporting Anchor & Disclosure
- Novo Nordisk A/S, Denmark
Where are we Heading? The US and EU Industry associations’ perspective
Olivia Shopshear, MS
- Senior Director, Science and Regulatory Advocacy
- Pharmaceutical Research and Manufacturers of America (PhRMA), United States
Sini Eskola, MPharm, MSc
- Director Regulatory Affairs
- European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium